UnitedHealth Group Incorporated

As of June 30, 2026, UnitedHealth Group Incorporated Shs Cert Deposito Arg Repr 0.03030303 carries a market capitalization of 549.65T, placing it among publicly traded companies globally. Its enterprise value stands at 622.88T, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

UnitedHealth Group Incorporated Shs Cert Deposito Arg Repr 0.03030303's next confirmed earnings release is scheduled for January 20, 2027.

As of June 30, 2026, UnitedHealth Group Incorporated Shs Cert Deposito Arg Repr 0.03030303 has 27.90B shares outstanding.

As of June 30, 2026, UnitedHealth Group Incorporated Shs Cert Deposito Arg Repr 0.03030303 trades at a trailing price-to-earnings ratio of 26.25. The price-to-sales ratio is 0.82, and the price-to-book ratio stands at 3.76.

As of June 30, 2026, UnitedHealth Group Incorporated Shs Cert Deposito Arg Repr 0.03030303 trades at an EV/EBITDA multiple of 16.17 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 0.93 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 19.37 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. UnitedHealth Group Incorporated Shs Cert Deposito Arg Repr 0.03030303 trades at an EV/FCF ratio of 15.58, comparing the total takeover cost of the business to the cash it actually generates for all capital providers. These enterprise value multiples are built on an enterprise value of 622.88T versus a market cap of 549.65T, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, UnitedHealth Group Incorporated Shs Cert Deposito Arg Repr 0.03030303 maintains a current ratio of 0.78, meaning it holds 0.8x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 69.21, indicating elevated leverage, while an interest coverage ratio of 6.67 demonstrates adequate ability to service its debt obligations.

Over the twelve months ended June 30, 2026, UnitedHealth Group Incorporated Shs Cert Deposito Arg Repr 0.03030303 posted a return on equity (ROE) of 14.62, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) comes in at 10.20 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) stands at 4.57, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 9.17, useful for judging operating efficiency across full business cycles. The company generates approximately 1.70B in revenue per employee across its workforce of 392,500.00, a quick read on workforce productivity versus industry peers.

Over the twelve months ended June 30, 2026, UnitedHealth Group Incorporated Shs Cert Deposito Arg Repr 0.03030303 recorded 3.75T in income tax expense. That works out to an effective tax rate of 14.50, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 25.87T, leaving 20.95T in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 22, 2026, UnitedHealth Group Incorporated Shs Cert Deposito Arg Repr 0.03030303's stock has gained approximately 20.30% over the past 52 weeks. The 50-day moving average sits at 18,898.00, while the 200-day moving average is 16,746.80.

Over the twelve months ended June 30, 2026, UnitedHealth Group Incorporated Shs Cert Deposito Arg Repr 0.03030303 generated 667.77T in revenue and converted that into 20.95T in net income, yielding earnings per share of 789.81. EBITDA reached 38.51T, while operating income came in at 32.16T.

As of June 30, 2026, UnitedHealth Group Incorporated Shs Cert Deposito Arg Repr 0.03030303 holds 46.68T in cash and equivalents against 108.78T in total debt, resulting in a net debt position of 66.38T. Total book value stands at 146.05T, with working capital of -37.03T providing operational flexibility.

UnitedHealth Group Incorporated Shs Cert Deposito Arg Repr 0.03030303 produced 40.08T in operating cash flow over the twelve months ended June 30, 2026. After subtracting -5.04T in capital expenditures, free cash flow totaled 35.04T - equivalent to 1,255.30 per share.

Over the twelve months ended June 30, 2026, UnitedHealth Group Incorporated Shs Cert Deposito Arg Repr 0.03030303 posted a gross margin of 19.51, reflecting its pricing power and cost economics. The operating margin of 4.82 and net profit margin of 3.14 provide insight into operational efficiency.

Over the twelve months ended June 30, 2026, UnitedHealth Group Incorporated Shs Cert Deposito Arg Repr 0.03030303 paid dividends of 430.32 per share. The dividend payout ratio of 51.56 indicates the proportion of earnings distributed to shareholders, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Free cash flow yield stands at 6.35, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield reaches 4.16, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to UnitedHealth Group Incorporated Shs Cert Deposito Arg Repr 0.03030303 shareholders.

As of June 30, 2026, UnitedHealth Group Incorporated Shs Cert Deposito Arg Repr 0.03030303 has an Altman Z-Score of 4.62, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.